Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2020 1
2021 5
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
Sex Differences in the Evolution of Neutralizing Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2.
Grzelak L, Velay A, Madec Y, Gallais F, Staropoli I, Schmidt-Mutter C, Wendling MJ, Meyer N, Planchais C, Rey D, Mouquet H, Reix N, Glady L, Hansmann Y, Bruel T, De Sèze J, Fontanet A, Gonzalez M, Schwartz O, Fafi-Kremer S. Grzelak L, et al. Among authors: glady l. J Infect Dis. 2021 Sep 17;224(6):983-988. doi: 10.1093/infdis/jiab127. J Infect Dis. 2021. PMID: 33693749 Free PMC article.
COVID-19 exposure in SARS-CoV-2-seropositive hospital staff members during the first pandemic wave at Strasbourg University Hospital, France.
Velay A, Gallais F, Wendling MJ, Bayer S, Reix N, Schneider A, Glady L, Collongues N, Lessinger JM, Hansmann Y, Kling-Pillitteri L, De Sèze J, Gonzalez M, Schmidt-Mutter C, Meyer N, Fafi-Kremer S. Velay A, et al. Among authors: glady l. Infect Dis Now. 2022 Feb;52(1):23-30. doi: 10.1016/j.idnow.2021.11.002. Epub 2021 Nov 11. Infect Dis Now. 2022. PMID: 34775140 Free PMC article.
Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection.
Gallais F, Gantner P, Bruel T, Velay A, Planas D, Wendling MJ, Bayer S, Solis M, Laugel E, Reix N, Schneider A, Glady L, Panaget B, Collongues N, Partisani M, Lessinger JM, Fontanet A, Rey D, Hansmann Y, Kling-Pillitteri L, Schwartz O, De Sèze J, Meyer N, Gonzalez M, Schmidt-Mutter C, Fafi-Kremer S. Gallais F, et al. Among authors: glady l. EBioMedicine. 2021 Sep;71:103561. doi: 10.1016/j.ebiom.2021.103561. Epub 2021 Aug 27. EBioMedicine. 2021. PMID: 34455390 Free PMC article.
[POCT-management during the first wave of Covid-19 in France. Results of a national survey leaded by the SFBC-POCT Working Group].
Glady L, Moal V, Benz-De Bretagne I, Bouvier D, Di Giovanni F, Chenevier-Gobeaux C, Jeannesson E, Jolly E, Kadi H, Oueidat N, Pernet P, Pieroni L, Poupon C, Toussaint-Hacquard M, Dubos M, Martinel I, Chauzit E, Beauvieux MC; Membres du groupe de travail « SFBC Marqueurs biochimiques COVID-19 ». Glady L, et al. Ann Biol Clin (Paris). 2021 Dec 1;79(6):535-549. doi: 10.1684/abc.2021.1685. Ann Biol Clin (Paris). 2021. PMID: 34961737 French.
Impact of intravenous lidocaine on clinical outcomes of patients with ARDS during COVID-19 pandemia (LidoCovid): A structured summary of a study protocol for a randomised controlled trial.
Muller M, Lefebvre F, Harlay ML, Glady L, Becker G, Muller C, Aberkane O, Tawk M, Julians M, Romoli A, Hecketsweiler S, Schneider F, Pottecher J, Chamaraux-Tran TN. Muller M, et al. Among authors: glady l. Trials. 2021 Feb 11;22(1):131. doi: 10.1186/s13063-021-05095-x. Trials. 2021. PMID: 33573681 Free PMC article.